Sector consensus Akeso, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:39:20 10/04/2026 pm IST			5-day change	1st Jan Change
138.20 ^HKD	+1.99%		-1.64%	+22.30%

07/04	Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026	CI
31/03	Akeso, Inc. Announces the Results of Health-Related Quality of Life Data from the HARMONi-2 Study At the 2026 European Lung Cancer Congress	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
AKESO, INC.			151.36	+25.63%	21
ARGENX SE			841.21	+23.35%	15
WUXI APPTEC CO., LTD.			134.62	+26.61%	18
INSMED INCORPORATED			212.15	+37.04%	20
BIONTECH SE			112.83	+38.68%	18
WUXI BIOLOGICS (CAYMAN) INC.			39.6	+26.43%	21
GENMAB A/S			2,232.52	+24.72%	14
SUMMIT THERAPEUTICS INC.			22.9	+54.25%	14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			533.22	+8.16%	17
MADRIGAL PHARMACEUTICALS, INC.			668.57	+28.67%	14
EXELIXIS, INC.			46.83	+5.79%	18
REMEGEN CO., LTD.			93.89	+0.81%	15
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	7,70,000	+40.77%	1
ARROWHEAD PHARMACEUTICALS, INC.			81.09	+24.49%	11
VAXCYTE, INC.			109	+79.04%	9
NUVALENT, INC.			142.39	+38.59%	18
CYTOKINETICS, INCORPORATED			92.82	+42.78%	17
PHARMAESSENTIA CORPORATION			757	+17.18%	7
IMMUNITYBIO, INC.			14.8	+103.3%	5
BELITE BIO, INC			211.5	+22.42%	8
Average			38,824.92	+33.44%	14
Weighted average by Cap.			21,483.49	+30.73%	16